SELDI-TOF MS Combined with Magnetic Beads for Detecting Serum Protein Biomarkers and Establishment of a Boosting Decision Tree Model for Diagnosis of Pancreatic Cancer

被引:9
作者
Qian, Jing-Yi [2 ]
Mou, Si-Hua [1 ]
Liu, Chi-Bo [1 ]
机构
[1] Taizhou Municipal Hosp, Dept Clin Lab, Taizhou, Zhejiang, Peoples R China
[2] Taizhou Municipal Hosp, Med Serv Sect, Taizhou, Zhejiang, Peoples R China
关键词
Pancreatic cancer; biomarker; protein; SELDI-TOF-MS; diagnosis; PROSTATE-CANCER; GASTRIC-CANCER; IDENTIFICATION;
D O I
10.7314/APJCP.2012.13.5.1911
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: New technologies for the early detection of pancreatic cancer (PC) are urgently needed. The aim of the present study was to screen for the potential protein biomarkers in serum using proteomic fingerprint technology. Methods: Magnetic beads combined with surface-enhanced laser desorption/ ionization (SELDI) TOF MS were used to profile and compare the protein spectra of serum samples from 85 patients with pancreatic cancer, 50 patients with acute-on-chronic pancreatitis and 98 healthy blood donors. Proteomic patterns associated with pancreatic cancer were identified with Biomarker Patterns Software. Results: A total of 37 differential m/z peaks were identified that were related to PC (P < 0.01). A tree model of biomarkers was constructed with the software based on the three biomarkers (7762 Da, 8560 Da, 11654 Da), this showing excellent separation between pancreatic cancer and non-cancer., with a sensitivity of 93.3% and a specificity of 95.6%. Blind test data showed a sensitivity of 88% and a specificity of 91.4%. Conclusions: The results suggested that serum biomarkers for pancreatic cancer can be detected using SELDI-TOF-MS combined with magnetic beads. Application of combined biomarkers may provide a powerful and reliable diagnostic method for pancreatic cancer with a high sensitivity and specificity.
引用
收藏
页码:1911 / 1915
页数:5
相关论文
共 20 条
[1]  
Adam BL, 2002, CANCER RES, V62, P3609
[2]  
[Anonymous], GASTROENTEROLOGY
[3]   Identification of gastric cancer patients by serum protein profiling [J].
Ebert, MPA ;
Meuer, J ;
Wiemer, JC ;
Schulz, HU ;
Reymond, MA ;
Traugott, U ;
Malfertheiner, P ;
Röcken, C .
JOURNAL OF PROTEOME RESEARCH, 2004, 3 (06) :1261-1266
[4]   New serum biomarkers for detection of esophageal carcinoma using Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry [J].
Guo, Renyong ;
Pan, Chunqin ;
Shen, Jianmin ;
Liu, Chibo .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (03) :513-519
[5]   The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome [J].
Hortin, Glen L. .
CLINICAL CHEMISTRY, 2006, 52 (07) :1223-1237
[6]   Advances in pancreatic cancer [J].
Kim, Edward J. ;
Simeone, Diane M. .
CURRENT OPINION IN GASTROENTEROLOGY, 2011, 27 (05) :460-466
[7]   Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population [J].
Kim, JE ;
Lee, KT ;
Lee, JK ;
Paik, SW ;
Rhee, JC ;
Choi, KW .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (02) :182-186
[8]   Pancreatic cancer [J].
Li, DH ;
Xie, KP ;
Wolff, R ;
Abbruzzese, JL .
LANCET, 2004, 363 (9414) :1049-1057
[9]   Serum proteomic patterns for gastric lesions as revealed by SELDI mass spectrometry [J].
Liang, Yong ;
Fang, Marong ;
Li, Jicheng ;
Liu, Chi Bo ;
Rudd, John A. ;
Kung, H. F. ;
Yew, David T. W. .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2006, 81 (02) :176-180
[10]   Written in blood [J].
Liotta, LA ;
Ferrari, M ;
Petricoin, E .
NATURE, 2003, 425 (6961) :905-905